Zonisamide Capsules USP, 100 mg, 90-count bottle, Rx Only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-775-90
Published June 1, 2022 · Recall initiated: May 13, 2022
Summary
FDA records drug Class II recall D-0888-2022, published June 1, 2022 and initiated May 13, 2022. Recalling firm: Direct Rx; Status: Terminated; Reported quantity: 16 bottles; Lot: Lot: 23JY2124 Exp. 6/30/23. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Direct Rx
- Distributor
- Nationwide to the U.S. market
- Lot
- Lot: 23JY2124 Exp. 6/30/23
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534,November 4, 2026
- FDADULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC 61919-482-60), 60 Caps; CYMBALTA, PackagedJuly 1, 2026
- FDADuloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx, Dist. ByAugust 13, 2025
- FDADuloxetine D/R, 30 mg, 30 Caps, RX Only, Packaged as a) 30-count bottle NDC 61919-0482-30, b) 60-count bottle,August 13, 2025
- FDALosartan HCTZ 100/12.5 mg, 90 count bottles NDC# 70518-2564-00 Repackaged NDC Original NDC # 68180-0216-09June 1, 2022
- FDADaytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, RxJune 1, 2022
Questions about this recall
Was Zonisamide Capsules USP, 100 mg, 90-count bottle, Rx Only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-775-90 recalled?
Yes. FDA published recall D-0888-2022 on June 1, 2022. Reported hazard: CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
What should I do if I have this product?
Voluntary: Firm initiated · Letter